Roche’s Genentech is backing this year’s Walk to End Lupus Now, taking up a sponsorship opportunity claimed by GSK in ...
New drug manufacturer Neion Bio has emerged from stealth after incubating a novel way to cook up biologic drugs. After its ...
Kennedy Jr.-led HHS’ vaccine agenda, invalidating recent changes to the CDC’s pediatric vaccine schedule and blocking ...
Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
The FDA has given the all-clear to Corcept’s class-first Lifyorli (relacorilant) to treat adults with platinum-resistant ...
Ionis Pharmaceuticals is dramatically lowering the price of its blockbuster hopeful Tryngolza (olezarsen) as it prepares to ...
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease, breaking the ...
After attracting GSK with its subcutaneous delivery tech at the top of the year, South Korea’s Alteogen has snared another ...
Healthcare professionals aren’t immune to societal shifts toward gathering information from artificial intelligence tools, social media and streaming content, opening up new opportunities for healt | ...
Novartis is facing a class-action lawsuit alleging it shared, without patients’ consent, sensitive health information it ...
Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...
Takeda is setting the stage for a sweeping new round of restructuring, aiming to streamline operations to bankroll upcoming ...
Over the last seven months, Boehringer Ingelheim has gained approvals and label expansions in the U.S. for two of its newest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results